| 7.1 |
42.7 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 6.0 |
17.9 |
GO:1904316 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 5.7 |
17.0 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 5.1 |
5.1 |
GO:0043491 |
protein kinase B signaling(GO:0043491) |
| 4.7 |
9.4 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 4.6 |
13.9 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 4.6 |
18.3 |
GO:0051796 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 4.4 |
13.1 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 4.1 |
20.3 |
GO:0051622 |
negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 4.0 |
28.3 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 3.7 |
14.6 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 3.5 |
10.6 |
GO:0061193 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 3.3 |
39.3 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
| 3.2 |
9.6 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 3.1 |
6.1 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 3.0 |
12.2 |
GO:0086092 |
regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 3.0 |
15.0 |
GO:0021623 |
optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 3.0 |
56.8 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 3.0 |
5.9 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 2.9 |
20.1 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 2.8 |
2.8 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 2.8 |
2.8 |
GO:0032461 |
positive regulation of protein oligomerization(GO:0032461) |
| 2.8 |
16.6 |
GO:0042335 |
cuticle development(GO:0042335) |
| 2.7 |
8.2 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 2.7 |
10.8 |
GO:0007499 |
ectoderm and mesoderm interaction(GO:0007499) |
| 2.6 |
7.8 |
GO:0043449 |
cellular alkene metabolic process(GO:0043449) |
| 2.5 |
7.6 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 2.5 |
10.0 |
GO:0051710 |
regulation of cytolysis in other organism(GO:0051710) |
| 2.5 |
2.5 |
GO:0045807 |
positive regulation of endocytosis(GO:0045807) |
| 2.4 |
7.2 |
GO:0045360 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 2.4 |
7.2 |
GO:0060915 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) fibroblast growth factor receptor signaling pathway involved in mammary gland specification(GO:0060595) mammary gland bud formation(GO:0060615) branch elongation involved in salivary gland morphogenesis(GO:0060667) mesenchymal cell differentiation involved in lung development(GO:0060915) |
| 2.4 |
16.6 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 2.3 |
7.0 |
GO:0098736 |
regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 2.3 |
2.3 |
GO:0018277 |
protein deamination(GO:0018277) |
| 2.3 |
16.1 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 2.3 |
6.9 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 2.3 |
47.9 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 2.3 |
41.1 |
GO:0015816 |
glycine transport(GO:0015816) |
| 2.3 |
15.8 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 2.2 |
8.7 |
GO:0010983 |
positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 2.1 |
6.4 |
GO:0071109 |
superior temporal gyrus development(GO:0071109) |
| 2.1 |
2.1 |
GO:0097017 |
renal protein absorption(GO:0097017) |
| 2.1 |
4.1 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 2.0 |
8.1 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 2.0 |
19.9 |
GO:1990834 |
response to odorant(GO:1990834) |
| 2.0 |
17.8 |
GO:0032348 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 1.9 |
9.7 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 1.9 |
13.4 |
GO:0043163 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 1.9 |
5.7 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 1.9 |
69.0 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 1.9 |
5.6 |
GO:1903452 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 1.8 |
1.8 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 1.8 |
5.5 |
GO:0015728 |
mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 1.8 |
9.2 |
GO:1904450 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 1.8 |
7.4 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
| 1.8 |
18.3 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.8 |
43.9 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 1.7 |
1.7 |
GO:0002784 |
regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
| 1.7 |
12.1 |
GO:1902164 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 1.7 |
1.7 |
GO:2001035 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 1.7 |
8.5 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 1.7 |
5.1 |
GO:1903572 |
regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.7 |
5.1 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 1.7 |
5.0 |
GO:0061713 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 1.7 |
8.3 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 1.6 |
4.9 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 1.6 |
9.7 |
GO:0030421 |
defecation(GO:0030421) |
| 1.6 |
4.9 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 1.6 |
6.5 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 1.6 |
3.2 |
GO:0060734 |
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 1.6 |
6.4 |
GO:0046833 |
positive regulation of RNA export from nucleus(GO:0046833) |
| 1.6 |
4.8 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 1.6 |
12.8 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 1.6 |
1.6 |
GO:0031077 |
post-embryonic camera-type eye development(GO:0031077) |
| 1.6 |
6.4 |
GO:1904199 |
positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 1.6 |
1.6 |
GO:1901532 |
regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
| 1.6 |
9.5 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 1.6 |
1.6 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 1.5 |
1.5 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.5 |
4.6 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 1.5 |
7.7 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 1.5 |
4.6 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 1.5 |
9.1 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.5 |
6.1 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 1.5 |
12.1 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 1.5 |
4.5 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 1.5 |
7.3 |
GO:1903906 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 1.5 |
7.3 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 1.4 |
2.9 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 1.4 |
25.9 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 1.4 |
14.4 |
GO:0071639 |
positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 1.4 |
1.4 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 1.4 |
4.3 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 1.4 |
11.2 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 1.4 |
4.1 |
GO:1902173 |
negative regulation of keratinocyte apoptotic process(GO:1902173) |
| 1.4 |
2.7 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 1.4 |
4.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 1.4 |
4.1 |
GO:0060697 |
positive regulation of phospholipid catabolic process(GO:0060697) |
| 1.4 |
9.5 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 1.4 |
4.1 |
GO:0048627 |
myoblast development(GO:0048627) |
| 1.3 |
2.7 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.3 |
10.7 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 1.3 |
9.2 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.3 |
4.0 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 1.3 |
3.9 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 1.3 |
3.9 |
GO:0045608 |
negative regulation of auditory receptor cell differentiation(GO:0045608) |
| 1.3 |
3.9 |
GO:0052553 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 1.3 |
5.2 |
GO:0009956 |
radial pattern formation(GO:0009956) |
| 1.3 |
5.1 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 1.3 |
1.3 |
GO:0010482 |
epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 1.3 |
12.7 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 1.3 |
12.7 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) |
| 1.3 |
15.2 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 1.3 |
12.5 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 1.2 |
8.7 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 1.2 |
8.7 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 1.2 |
8.6 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 1.2 |
1.2 |
GO:0060738 |
epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 1.2 |
3.6 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 1.2 |
3.6 |
GO:1990029 |
atrial ventricular junction remodeling(GO:0003294) atrial cardiac muscle cell to AV node cell communication by electrical coupling(GO:0086044) bundle of His cell to Purkinje myocyte communication by electrical coupling(GO:0086054) Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling(GO:0086055) regulation of Purkinje myocyte action potential(GO:0098906) vasomotion(GO:1990029) |
| 1.2 |
4.8 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 1.2 |
4.8 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 1.2 |
2.4 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 1.2 |
19.1 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 1.2 |
4.6 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 1.2 |
3.5 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 1.1 |
4.6 |
GO:1990169 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 1.1 |
9.1 |
GO:0030578 |
PML body organization(GO:0030578) |
| 1.1 |
3.4 |
GO:0046963 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 1.1 |
1.1 |
GO:1902256 |
apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 1.1 |
16.6 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 1.1 |
3.3 |
GO:1903121 |
regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.1 |
1.1 |
GO:0002386 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 1.1 |
6.5 |
GO:1902045 |
negative regulation of Fas signaling pathway(GO:1902045) |
| 1.1 |
4.3 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 1.1 |
1.1 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 1.1 |
7.5 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 1.1 |
9.6 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.1 |
1.1 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 1.1 |
2.1 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 1.1 |
6.3 |
GO:1904222 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 1.1 |
1.1 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 1.0 |
1.0 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 1.0 |
1.0 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 1.0 |
12.4 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 1.0 |
4.1 |
GO:0090096 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.0 |
19.4 |
GO:0002138 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 1.0 |
4.1 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 1.0 |
50.5 |
GO:0043616 |
keratinocyte proliferation(GO:0043616) |
| 1.0 |
15.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 1.0 |
8.0 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 1.0 |
9.9 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 1.0 |
10.9 |
GO:0001660 |
fever generation(GO:0001660) |
| 1.0 |
2.0 |
GO:0090032 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 1.0 |
5.9 |
GO:0018032 |
protein amidation(GO:0018032) |
| 1.0 |
1.0 |
GO:1901205 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 1.0 |
5.8 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 1.0 |
2.9 |
GO:1904237 |
regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 1.0 |
2.9 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 1.0 |
1.9 |
GO:0060413 |
atrial septum morphogenesis(GO:0060413) |
| 1.0 |
24.8 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 1.0 |
3.8 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.9 |
0.9 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.9 |
4.7 |
GO:0030822 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.9 |
3.7 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 0.9 |
2.8 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.9 |
6.5 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.9 |
4.6 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.9 |
7.4 |
GO:1901297 |
arterial endothelial cell fate commitment(GO:0060844) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.9 |
15.7 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.9 |
6.4 |
GO:0061146 |
Peyer's patch morphogenesis(GO:0061146) |
| 0.9 |
30.8 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.9 |
1.8 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.9 |
3.6 |
GO:1904799 |
negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.9 |
2.7 |
GO:0060545 |
positive regulation of necroptotic process(GO:0060545) |
| 0.9 |
4.5 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.9 |
22.3 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.9 |
3.6 |
GO:0001971 |
negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.9 |
5.3 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.9 |
4.4 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.9 |
9.7 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.9 |
6.1 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.9 |
7.9 |
GO:0035290 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.9 |
2.6 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.9 |
2.6 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.9 |
2.6 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.9 |
2.6 |
GO:0032707 |
negative regulation of interleukin-23 production(GO:0032707) |
| 0.9 |
4.3 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.9 |
5.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.9 |
6.0 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.9 |
3.4 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.9 |
4.3 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.9 |
13.6 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.8 |
1.7 |
GO:0035627 |
ceramide transport(GO:0035627) |
| 0.8 |
2.5 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.8 |
13.5 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.8 |
4.2 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.8 |
2.5 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.8 |
5.8 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.8 |
2.5 |
GO:1902722 |
positive regulation of prolactin secretion(GO:1902722) |
| 0.8 |
4.1 |
GO:0090649 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.8 |
4.1 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.8 |
5.7 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.8 |
2.4 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 0.8 |
6.5 |
GO:1902714 |
negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.8 |
9.7 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.8 |
7.3 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.8 |
2.4 |
GO:0098886 |
modification of dendritic spine(GO:0098886) |
| 0.8 |
0.8 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.8 |
3.2 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.8 |
2.4 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.8 |
3.2 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.8 |
2.4 |
GO:0071030 |
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.8 |
2.4 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.8 |
11.9 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.8 |
6.3 |
GO:0032485 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.8 |
4.0 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.8 |
3.2 |
GO:0002442 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.8 |
1.6 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) |
| 0.8 |
1.6 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.8 |
5.5 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.8 |
0.8 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.8 |
12.4 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.8 |
2.3 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.8 |
3.0 |
GO:0001808 |
negative regulation of type IV hypersensitivity(GO:0001808) |
| 0.8 |
20.6 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.8 |
2.3 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.8 |
9.9 |
GO:1902961 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.8 |
1.5 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.7 |
1.5 |
GO:2000412 |
positive regulation of thymocyte migration(GO:2000412) |
| 0.7 |
3.7 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.7 |
6.0 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.7 |
7.5 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.7 |
3.0 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.7 |
5.2 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.7 |
9.6 |
GO:2000680 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.7 |
3.7 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.7 |
1.5 |
GO:0006738 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 0.7 |
11.6 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.7 |
2.9 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.7 |
2.9 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.7 |
2.2 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.7 |
2.2 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.7 |
0.7 |
GO:1904292 |
regulation of ERAD pathway(GO:1904292) |
| 0.7 |
0.7 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.7 |
2.9 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.7 |
1.4 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.7 |
1.4 |
GO:0023016 |
signal transduction by trans-phosphorylation(GO:0023016) |
| 0.7 |
5.7 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.7 |
11.3 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.7 |
2.8 |
GO:0033088 |
regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.7 |
6.3 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.7 |
2.8 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.7 |
6.3 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.7 |
2.1 |
GO:0006117 |
acetaldehyde metabolic process(GO:0006117) |
| 0.7 |
3.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.7 |
4.2 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.7 |
0.7 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.7 |
11.1 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.7 |
2.1 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.7 |
3.4 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.7 |
19.0 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.7 |
1.4 |
GO:0060532 |
bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
| 0.7 |
1.4 |
GO:1904351 |
negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 0.7 |
2.7 |
GO:1904180 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.7 |
4.7 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.7 |
0.7 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.7 |
7.3 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.7 |
15.9 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.7 |
1.3 |
GO:1901526 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.7 |
13.9 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.7 |
3.3 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.7 |
2.6 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.7 |
2.0 |
GO:1903674 |
regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.7 |
7.2 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.7 |
12.4 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.7 |
0.7 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.6 |
3.9 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.6 |
0.6 |
GO:0042789 |
mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.6 |
1.9 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.6 |
2.6 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.6 |
3.8 |
GO:0006145 |
purine nucleobase catabolic process(GO:0006145) |
| 0.6 |
1.3 |
GO:0002428 |
antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.6 |
2.6 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.6 |
0.6 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.6 |
3.2 |
GO:0006050 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.6 |
5.1 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.6 |
1.3 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.6 |
1.9 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.6 |
1.3 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.6 |
1.3 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.6 |
3.7 |
GO:1901911 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.6 |
1.9 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.6 |
1.9 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.6 |
1.2 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.6 |
1.9 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.6 |
1.2 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.6 |
7.4 |
GO:0015884 |
folic acid transport(GO:0015884) |
| 0.6 |
8.6 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.6 |
1.8 |
GO:0003206 |
cardiac chamber morphogenesis(GO:0003206) |
| 0.6 |
0.6 |
GO:0072268 |
pattern specification involved in metanephros development(GO:0072268) |
| 0.6 |
3.0 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.6 |
3.6 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.6 |
3.6 |
GO:1900827 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.6 |
3.0 |
GO:0008050 |
female courtship behavior(GO:0008050) |
| 0.6 |
3.6 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.6 |
1.8 |
GO:0006429 |
leucyl-tRNA aminoacylation(GO:0006429) |
| 0.6 |
2.4 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.6 |
9.0 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.6 |
1.8 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.6 |
1.8 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.6 |
0.6 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
| 0.6 |
1.2 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.6 |
1.8 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.6 |
10.6 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.6 |
1.2 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.6 |
2.9 |
GO:0045631 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.6 |
1.8 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.6 |
14.6 |
GO:0060004 |
reflex(GO:0060004) |
| 0.6 |
0.6 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.6 |
11.6 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.6 |
1.7 |
GO:0032667 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
| 0.6 |
1.2 |
GO:1904796 |
regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.6 |
2.9 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.6 |
11.6 |
GO:1904259 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.6 |
1.2 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.6 |
2.9 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.6 |
1.7 |
GO:0070944 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.6 |
2.3 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.6 |
3.4 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.6 |
1.7 |
GO:1903033 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.6 |
9.0 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.6 |
1.1 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.6 |
2.2 |
GO:1903233 |
regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
| 0.6 |
5.0 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.6 |
4.5 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.6 |
2.8 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.6 |
2.8 |
GO:0036414 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.6 |
1.1 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.6 |
1.7 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 0.6 |
1.1 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
| 0.5 |
4.9 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.5 |
1.6 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.5 |
1.1 |
GO:0010751 |
negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.5 |
2.7 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.5 |
5.5 |
GO:1903672 |
positive regulation of sprouting angiogenesis(GO:1903672) |
| 0.5 |
2.2 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.5 |
1.1 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.5 |
6.5 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.5 |
2.7 |
GO:0031650 |
regulation of heat generation(GO:0031650) |
| 0.5 |
2.2 |
GO:1902744 |
negative regulation of lamellipodium organization(GO:1902744) |
| 0.5 |
8.5 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.5 |
2.1 |
GO:1903381 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.5 |
1.6 |
GO:0072738 |
response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.5 |
1.6 |
GO:0061428 |
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.5 |
9.6 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.5 |
6.4 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 0.5 |
2.1 |
GO:1902661 |
positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.5 |
41.9 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.5 |
5.3 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.5 |
0.5 |
GO:1903902 |
positive regulation of viral life cycle(GO:1903902) |
| 0.5 |
0.5 |
GO:1902041 |
regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902041) |
| 0.5 |
1.0 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.5 |
2.1 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.5 |
10.4 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.5 |
2.6 |
GO:0001909 |
leukocyte mediated cytotoxicity(GO:0001909) |
| 0.5 |
2.1 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.5 |
4.1 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.5 |
4.6 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.5 |
2.1 |
GO:1904978 |
regulation of endosome organization(GO:1904978) |
| 0.5 |
3.1 |
GO:0043415 |
positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.5 |
1.0 |
GO:0003151 |
outflow tract morphogenesis(GO:0003151) |
| 0.5 |
2.6 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.5 |
1.0 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.5 |
4.0 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.5 |
2.5 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.5 |
0.5 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.5 |
1.5 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.5 |
4.5 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.5 |
2.5 |
GO:0009804 |
coumarin metabolic process(GO:0009804) |
| 0.5 |
1.0 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.5 |
1.5 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.5 |
7.4 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.5 |
2.5 |
GO:0002282 |
microglial cell activation involved in immune response(GO:0002282) |
| 0.5 |
5.4 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.5 |
4.4 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.5 |
0.5 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.5 |
1.0 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.5 |
2.9 |
GO:0070458 |
cellular detoxification of nitrogen compound(GO:0070458) |
| 0.5 |
3.4 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.5 |
1.5 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.5 |
4.8 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.5 |
1.5 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.5 |
0.5 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.5 |
1.0 |
GO:0071611 |
macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) positive regulation of granulocyte colony-stimulating factor production(GO:0071657) regulation of macrophage colony-stimulating factor production(GO:1901256) positive regulation of macrophage colony-stimulating factor production(GO:1901258) |
| 0.5 |
0.5 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.5 |
1.0 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.5 |
1.0 |
GO:2000729 |
positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 0.5 |
1.4 |
GO:0048007 |
antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.5 |
3.8 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.5 |
1.4 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.5 |
1.9 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.5 |
0.9 |
GO:1904181 |
positive regulation of membrane depolarization(GO:1904181) |
| 0.5 |
0.9 |
GO:0046066 |
dGDP metabolic process(GO:0046066) |
| 0.5 |
5.2 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.5 |
1.9 |
GO:0006726 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.5 |
3.3 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.5 |
0.5 |
GO:0007060 |
male meiosis chromosome segregation(GO:0007060) |
| 0.5 |
1.9 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.5 |
3.7 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.5 |
3.2 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.5 |
2.3 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.5 |
2.3 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.5 |
2.3 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.5 |
4.6 |
GO:1990441 |
negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
| 0.5 |
1.4 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 0.5 |
2.3 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.5 |
5.4 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.5 |
0.5 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.5 |
4.5 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.5 |
4.5 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.5 |
2.3 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.5 |
3.2 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.4 |
2.2 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.4 |
1.3 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.4 |
0.9 |
GO:0022037 |
metencephalon development(GO:0022037) |
| 0.4 |
1.3 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 0.4 |
4.0 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.4 |
1.3 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.4 |
0.4 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.4 |
4.0 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.4 |
4.9 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.4 |
2.6 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.4 |
1.3 |
GO:0045081 |
negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.4 |
1.3 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.4 |
0.9 |
GO:0010763 |
positive regulation of fibroblast migration(GO:0010763) |
| 0.4 |
2.2 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.4 |
1.7 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.4 |
0.4 |
GO:0030194 |
positive regulation of blood coagulation(GO:0030194) positive regulation of coagulation(GO:0050820) positive regulation of hemostasis(GO:1900048) |
| 0.4 |
0.4 |
GO:1990542 |
mitochondrial transmembrane transport(GO:1990542) |
| 0.4 |
2.2 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.4 |
3.0 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.4 |
2.6 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.4 |
1.3 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.4 |
11.1 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.4 |
4.7 |
GO:0048298 |
positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.4 |
2.1 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.4 |
1.3 |
GO:0044827 |
modulation by host of viral genome replication(GO:0044827) |
| 0.4 |
20.8 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.4 |
3.4 |
GO:0043622 |
cortical microtubule organization(GO:0043622) |
| 0.4 |
0.8 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.4 |
1.3 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.4 |
0.4 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.4 |
0.8 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.4 |
0.4 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.4 |
1.7 |
GO:2000435 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.4 |
0.8 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.4 |
3.7 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.4 |
0.4 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.4 |
1.7 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.4 |
1.2 |
GO:0070384 |
Harderian gland development(GO:0070384) |
| 0.4 |
2.9 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.4 |
4.1 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.4 |
0.4 |
GO:0002763 |
positive regulation of myeloid leukocyte differentiation(GO:0002763) |
| 0.4 |
2.5 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.4 |
4.5 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.4 |
1.2 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.4 |
0.4 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.4 |
1.2 |
GO:0046379 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.4 |
0.8 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.4 |
2.4 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.4 |
1.2 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.4 |
2.0 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.4 |
2.0 |
GO:0052027 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.4 |
8.1 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.4 |
0.8 |
GO:1902617 |
response to fluoride(GO:1902617) |
| 0.4 |
0.8 |
GO:0051446 |
positive regulation of meiotic cell cycle(GO:0051446) |
| 0.4 |
9.6 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.4 |
1.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.4 |
2.8 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.4 |
0.8 |
GO:1902965 |
regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.4 |
2.4 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.4 |
0.4 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.4 |
9.9 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.4 |
1.2 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.4 |
3.9 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.4 |
5.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.4 |
3.9 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.4 |
0.8 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.4 |
1.2 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.4 |
1.5 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.4 |
0.8 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.4 |
3.4 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.4 |
0.8 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.4 |
0.8 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.4 |
3.4 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.4 |
0.4 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.4 |
0.4 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.4 |
3.0 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.4 |
2.3 |
GO:0055011 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.4 |
6.4 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.4 |
0.4 |
GO:0097198 |
histone H3-K36 trimethylation(GO:0097198) |
| 0.4 |
3.7 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.4 |
0.4 |
GO:1902527 |
positive regulation of protein monoubiquitination(GO:1902527) |
| 0.4 |
0.4 |
GO:1904861 |
excitatory synapse assembly(GO:1904861) |
| 0.4 |
2.2 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.4 |
2.2 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.4 |
2.6 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.4 |
7.7 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) |
| 0.4 |
0.7 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.4 |
0.7 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
| 0.4 |
0.7 |
GO:0007338 |
single fertilization(GO:0007338) |
| 0.4 |
0.7 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.4 |
0.7 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.4 |
1.1 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.4 |
2.2 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.4 |
0.7 |
GO:0035878 |
nail development(GO:0035878) |
| 0.4 |
8.6 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.4 |
1.8 |
GO:0045359 |
positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.4 |
2.9 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.4 |
1.1 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.4 |
1.4 |
GO:1903445 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.4 |
0.7 |
GO:0032730 |
positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.4 |
4.3 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.4 |
0.7 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) |
| 0.4 |
0.4 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.4 |
2.1 |
GO:0033489 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.4 |
2.1 |
GO:0016098 |
monoterpenoid metabolic process(GO:0016098) |
| 0.4 |
3.5 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.4 |
1.8 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.4 |
0.7 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.4 |
3.9 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.4 |
1.8 |
GO:0016128 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.4 |
1.1 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.3 |
2.4 |
GO:0052696 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.3 |
3.1 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.3 |
2.8 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 |
1.0 |
GO:1903677 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.3 |
1.4 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.3 |
0.3 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.3 |
2.1 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.3 |
0.7 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.3 |
4.5 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.3 |
1.0 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.3 |
1.4 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.3 |
0.3 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.3 |
2.4 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.3 |
2.1 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.3 |
2.4 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.3 |
2.4 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.3 |
1.7 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.3 |
19.4 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.3 |
1.7 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.3 |
2.4 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 |
4.1 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.3 |
5.4 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.3 |
1.0 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.3 |
1.3 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.3 |
3.0 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.3 |
5.0 |
GO:0048535 |
lymph node development(GO:0048535) |
| 0.3 |
1.0 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.3 |
1.3 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 |
0.3 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.3 |
2.0 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.3 |
4.3 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.3 |
1.0 |
GO:1900108 |
negative regulation of nodal signaling pathway(GO:1900108) |
| 0.3 |
2.0 |
GO:0009407 |
toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.3 |
0.3 |
GO:0031120 |
snRNA pseudouridine synthesis(GO:0031120) |
| 0.3 |
3.6 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.3 |
1.6 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 |
0.6 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.3 |
1.9 |
GO:0060633 |
negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 0.3 |
4.2 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.3 |
1.6 |
GO:0060252 |
positive regulation of glial cell proliferation(GO:0060252) |
| 0.3 |
0.3 |
GO:0051873 |
disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.3 |
1.3 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.3 |
1.0 |
GO:0006210 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.3 |
1.9 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 |
0.6 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.3 |
1.6 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.3 |
0.3 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.3 |
1.9 |
GO:0006489 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.3 |
3.5 |
GO:0001953 |
negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.3 |
0.3 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.3 |
1.6 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.3 |
2.9 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.3 |
2.2 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.3 |
0.3 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.3 |
0.3 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.3 |
6.3 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.3 |
5.3 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.3 |
0.3 |
GO:0070341 |
fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 |
0.3 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.3 |
0.9 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.3 |
1.2 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.3 |
13.8 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.3 |
2.5 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 |
3.4 |
GO:0042355 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.3 |
1.2 |
GO:0033603 |
positive regulation of dopamine secretion(GO:0033603) |
| 0.3 |
3.4 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.3 |
1.5 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.3 |
4.0 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.3 |
2.4 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.3 |
0.6 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.3 |
1.2 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.3 |
0.6 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.3 |
3.6 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.3 |
1.5 |
GO:0003069 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.3 |
2.4 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.3 |
0.9 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.3 |
0.3 |
GO:1903094 |
negative regulation of protein deubiquitination(GO:0090086) regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.3 |
2.7 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.3 |
0.9 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.3 |
0.9 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.3 |
1.8 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.3 |
1.5 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.3 |
3.0 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.3 |
0.9 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 |
1.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 |
1.2 |
GO:0061209 |
cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.3 |
2.3 |
GO:0046959 |
habituation(GO:0046959) |
| 0.3 |
0.6 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.3 |
0.6 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.3 |
0.9 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.3 |
2.3 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.3 |
2.0 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
0.6 |
GO:0070253 |
somatostatin secretion(GO:0070253) |
| 0.3 |
1.4 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.3 |
0.9 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.3 |
1.1 |
GO:0035822 |
meiotic gene conversion(GO:0006311) gene conversion(GO:0035822) |
| 0.3 |
0.6 |
GO:0007439 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.3 |
4.9 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.3 |
0.3 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.3 |
0.3 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.3 |
3.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.3 |
4.0 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.3 |
2.8 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.3 |
6.5 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.3 |
2.6 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.3 |
1.1 |
GO:0001835 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.3 |
2.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.3 |
1.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.3 |
3.1 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.3 |
4.2 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.3 |
2.2 |
GO:0060051 |
negative regulation of protein glycosylation(GO:0060051) |
| 0.3 |
0.6 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.3 |
0.8 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.3 |
0.8 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.3 |
3.9 |
GO:0098789 |
pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.3 |
0.6 |
GO:0010980 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.3 |
1.1 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.3 |
0.8 |
GO:0038178 |
complement component C5a signaling pathway(GO:0038178) |
| 0.3 |
0.6 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.3 |
0.3 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.3 |
0.8 |
GO:0033602 |
negative regulation of dopamine secretion(GO:0033602) |
| 0.3 |
1.4 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.3 |
2.2 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.3 |
2.7 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.3 |
0.5 |
GO:0060605 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.3 |
0.5 |
GO:0033590 |
response to cobalamin(GO:0033590) |
| 0.3 |
1.1 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.3 |
0.5 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.3 |
1.6 |
GO:1905216 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.3 |
1.1 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.3 |
3.8 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.3 |
1.4 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.3 |
1.9 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.3 |
3.2 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.3 |
1.1 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.3 |
1.6 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.3 |
6.2 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.3 |
6.1 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.3 |
1.3 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.3 |
6.4 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.3 |
1.1 |
GO:0035522 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.3 |
4.0 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.3 |
0.8 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.3 |
1.6 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 |
2.7 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.3 |
0.8 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.3 |
1.3 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.3 |
27.3 |
GO:0009301 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.3 |
0.3 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.3 |
1.1 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.3 |
1.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.3 |
1.1 |
GO:0030856 |
regulation of epithelial cell differentiation(GO:0030856) |
| 0.3 |
1.1 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.3 |
0.3 |
GO:0001516 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.3 |
1.6 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.3 |
0.3 |
GO:0061097 |
regulation of protein tyrosine kinase activity(GO:0061097) |
| 0.3 |
0.5 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.3 |
2.1 |
GO:0043524 |
negative regulation of neuron apoptotic process(GO:0043524) |
| 0.3 |
1.6 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.3 |
1.3 |
GO:0070997 |
neuron death(GO:0070997) |
| 0.3 |
0.8 |
GO:0002441 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.3 |
4.7 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.3 |
2.3 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.3 |
1.0 |
GO:0042539 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.3 |
0.8 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.3 |
0.5 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.3 |
0.3 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.3 |
3.9 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.3 |
2.8 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.3 |
0.5 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.3 |
1.8 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.3 |
2.0 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.3 |
2.0 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 |
0.3 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 0.3 |
0.3 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.3 |
0.3 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.3 |
3.5 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.3 |
1.0 |
GO:0045586 |
regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.3 |
1.0 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.2 |
0.5 |
GO:0002888 |
positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
| 0.2 |
1.0 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 |
0.7 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.2 |
0.2 |
GO:1902186 |
regulation of viral release from host cell(GO:1902186) |
| 0.2 |
0.7 |
GO:0003214 |
cardiac left ventricle morphogenesis(GO:0003214) |
| 0.2 |
0.7 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.2 |
0.2 |
GO:1900086 |
positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
| 0.2 |
1.0 |
GO:0014042 |
positive regulation of neuron maturation(GO:0014042) |
| 0.2 |
1.2 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 |
3.0 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.2 |
27.0 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.2 |
4.0 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.2 |
2.7 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.2 |
3.2 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.2 |
4.7 |
GO:0032732 |
positive regulation of interleukin-1 production(GO:0032732) |
| 0.2 |
1.0 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.2 |
1.7 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 |
2.2 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.2 |
5.1 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.2 |
1.0 |
GO:0002003 |
angiotensin maturation(GO:0002003) |
| 0.2 |
0.5 |
GO:0009216 |
purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
| 0.2 |
0.2 |
GO:0002663 |
B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
| 0.2 |
1.5 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 |
0.5 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.2 |
4.3 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
| 0.2 |
0.5 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.2 |
6.5 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.2 |
0.2 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.2 |
0.5 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) |
| 0.2 |
1.2 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.2 |
0.5 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.2 |
0.2 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.2 |
1.7 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 |
1.2 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 |
0.2 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.2 |
0.9 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.2 |
5.0 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.2 |
0.2 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 |
0.7 |
GO:0070831 |
basement membrane assembly(GO:0070831) |
| 0.2 |
0.9 |
GO:1904806 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.2 |
0.2 |
GO:0090288 |
negative regulation of cellular response to growth factor stimulus(GO:0090288) |
| 0.2 |
1.4 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.2 |
0.2 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.2 |
0.2 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.2 |
0.2 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.2 |
4.9 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.2 |
2.8 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.2 |
0.2 |
GO:0016569 |
covalent chromatin modification(GO:0016569) |
| 0.2 |
1.6 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.2 |
0.7 |
GO:1900744 |
regulation of p38MAPK cascade(GO:1900744) |
| 0.2 |
0.7 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 0.2 |
0.2 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.2 |
3.7 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.2 |
0.7 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.2 |
0.9 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.2 |
0.2 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.2 |
13.5 |
GO:0046473 |
phosphatidic acid metabolic process(GO:0046473) |
| 0.2 |
0.7 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.2 |
0.5 |
GO:0072104 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.2 |
0.5 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.2 |
1.6 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
0.9 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.2 |
4.3 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.2 |
0.7 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.2 |
1.3 |
GO:0093001 |
glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 0.2 |
1.8 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
0.7 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.2 |
0.2 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.2 |
0.7 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.2 |
0.7 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
9.6 |
GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.2 |
1.1 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.2 |
0.9 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.2 |
0.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.2 |
0.4 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.2 |
0.9 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.2 |
0.2 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.2 |
0.2 |
GO:0033023 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 0.2 |
1.7 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 |
5.4 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.2 |
0.9 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 |
0.6 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.2 |
0.6 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.2 |
0.9 |
GO:0031112 |
positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
| 0.2 |
1.1 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.2 |
3.0 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.2 |
0.6 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.2 |
4.4 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 |
0.6 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.2 |
0.4 |
GO:0006864 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.2 |
0.6 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.2 |
1.9 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 |
0.4 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.2 |
1.3 |
GO:0033512 |
L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.2 |
1.5 |
GO:1990539 |
fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.2 |
4.4 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.2 |
1.5 |
GO:0045995 |
regulation of embryonic development(GO:0045995) |
| 0.2 |
2.7 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.2 |
0.6 |
GO:1902544 |
regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.2 |
0.4 |
GO:1905007 |
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
| 0.2 |
0.8 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.2 |
1.4 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 0.2 |
0.2 |
GO:0009441 |
glycolate metabolic process(GO:0009441) |
| 0.2 |
0.4 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.2 |
5.2 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.2 |
0.2 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.2 |
0.2 |
GO:1902514 |
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.2 |
0.4 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.2 |
0.4 |
GO:0046626 |
regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.2 |
0.6 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.2 |
11.9 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.2 |
3.8 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.2 |
1.6 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.2 |
0.2 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 |
6.2 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.2 |
2.8 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.2 |
2.2 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 0.2 |
1.4 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 |
2.2 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 |
0.6 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.2 |
1.6 |
GO:0046629 |
gamma-delta T cell activation(GO:0046629) |
| 0.2 |
0.2 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.2 |
0.8 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.2 |
0.4 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 |
0.6 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.2 |
33.5 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.2 |
1.9 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
0.4 |
GO:0007598 |
blood coagulation, extrinsic pathway(GO:0007598) |
| 0.2 |
1.0 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.2 |
0.6 |
GO:0006043 |
glucosamine catabolic process(GO:0006043) |
| 0.2 |
1.5 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.2 |
0.6 |
GO:1990922 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.2 |
2.3 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.2 |
1.1 |
GO:0038112 |
interleukin-8-mediated signaling pathway(GO:0038112) |
| 0.2 |
1.1 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.2 |
0.4 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.2 |
1.1 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 |
2.3 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.2 |
0.2 |
GO:0060462 |
lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
| 0.2 |
0.2 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.2 |
0.9 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.2 |
0.2 |
GO:1990791 |
dorsal root ganglion development(GO:1990791) |
| 0.2 |
0.4 |
GO:0060940 |
epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.2 |
0.8 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.2 |
2.8 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 |
0.4 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 |
1.1 |
GO:0060674 |
placenta blood vessel development(GO:0060674) |
| 0.2 |
0.2 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.2 |
0.4 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 |
0.2 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.2 |
3.7 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.2 |
0.4 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.2 |
5.6 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.2 |
0.4 |
GO:0030575 |
nuclear body organization(GO:0030575) |
| 0.2 |
0.4 |
GO:1990036 |
regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) calcium ion import into sarcoplasmic reticulum(GO:1990036) |
| 0.2 |
0.9 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.2 |
0.7 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.2 |
0.7 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.2 |
0.7 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.2 |
0.2 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.2 |
0.2 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.2 |
0.6 |
GO:2000489 |
regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.2 |
0.6 |
GO:0060574 |
intestinal epithelial cell maturation(GO:0060574) |
| 0.2 |
1.3 |
GO:0015727 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.2 |
0.6 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.2 |
0.4 |
GO:1903393 |
positive regulation of adherens junction organization(GO:1903393) |
| 0.2 |
1.3 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 |
1.3 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.2 |
1.5 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.2 |
1.4 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.2 |
0.5 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.2 |
0.5 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.2 |
2.9 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.2 |
3.6 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.2 |
2.3 |
GO:0014059 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.2 |
2.8 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.2 |
2.3 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.2 |
3.2 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.2 |
1.4 |
GO:0098779 |
mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.2 |
0.2 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 |
1.2 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.2 |
0.5 |
GO:1904587 |
response to glycoprotein(GO:1904587) |
| 0.2 |
0.2 |
GO:0060412 |
ventricular septum morphogenesis(GO:0060412) |
| 0.2 |
0.5 |
GO:0002372 |
myeloid dendritic cell cytokine production(GO:0002372) |
| 0.2 |
0.3 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.2 |
0.5 |
GO:1900075 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.2 |
0.5 |
GO:0098884 |
postsynaptic neurotransmitter receptor internalization(GO:0098884) |
| 0.2 |
3.8 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.2 |
0.7 |
GO:1902229 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
| 0.2 |
0.3 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.2 |
1.0 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 |
3.1 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.2 |
1.5 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.2 |
2.7 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.2 |
1.4 |
GO:0045329 |
carnitine biosynthetic process(GO:0045329) |
| 0.2 |
1.0 |
GO:1902916 |
positive regulation of protein polyubiquitination(GO:1902916) |
| 0.2 |
1.3 |
GO:0051583 |
dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.2 |
3.2 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.2 |
0.2 |
GO:0032881 |
regulation of polysaccharide metabolic process(GO:0032881) regulation of glycogen metabolic process(GO:0070873) |
| 0.2 |
0.5 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.2 |
0.5 |
GO:0033007 |
negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
| 0.2 |
1.0 |
GO:0035404 |
histone-serine phosphorylation(GO:0035404) |
| 0.2 |
1.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 |
0.3 |
GO:0001836 |
release of cytochrome c from mitochondria(GO:0001836) |
| 0.2 |
1.2 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.2 |
1.0 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.2 |
4.3 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.2 |
0.5 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.2 |
1.0 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.2 |
1.0 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.2 |
0.3 |
GO:0010700 |
negative regulation of norepinephrine secretion(GO:0010700) |
| 0.2 |
2.0 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.2 |
0.7 |
GO:0051413 |
response to cortisone(GO:0051413) |
| 0.2 |
0.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
1.5 |
GO:0051918 |
regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
| 0.2 |
0.7 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.2 |
1.5 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.2 |
0.5 |
GO:0014744 |
positive regulation of muscle adaptation(GO:0014744) |
| 0.2 |
0.2 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.2 |
1.1 |
GO:2001268 |
urokinase plasminogen activator signaling pathway(GO:0038195) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.2 |
0.6 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.2 |
0.2 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.2 |
0.8 |
GO:1904751 |
positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 |
6.4 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.2 |
10.6 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.2 |
0.5 |
GO:0045210 |
FasL biosynthetic process(GO:0045210) |
| 0.2 |
0.5 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.2 |
3.5 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.2 |
0.3 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.2 |
0.2 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.2 |
3.5 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.2 |
1.7 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.2 |
0.5 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.2 |
2.5 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.2 |
0.6 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.2 |
0.2 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.2 |
0.2 |
GO:0010939 |
regulation of necrotic cell death(GO:0010939) |
| 0.2 |
0.5 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.2 |
3.1 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.2 |
0.6 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.2 |
0.9 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.2 |
0.6 |
GO:0042749 |
regulation of circadian sleep/wake cycle(GO:0042749) |
| 0.2 |
5.8 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.2 |
0.8 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.2 |
1.2 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.2 |
0.3 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.2 |
0.2 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.2 |
0.3 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.2 |
0.3 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 |
0.5 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.2 |
0.9 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.1 |
0.9 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.1 |
0.6 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.1 |
2.2 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.1 |
1.3 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
0.7 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.1 |
1.9 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.1 |
1.6 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.1 |
0.4 |
GO:0051043 |
regulation of membrane protein ectodomain proteolysis(GO:0051043) negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 |
0.3 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.1 |
0.1 |
GO:0002589 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 |
1.0 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 |
0.1 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.1 |
1.0 |
GO:0060235 |
lens induction in camera-type eye(GO:0060235) |
| 0.1 |
0.6 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.1 |
0.4 |
GO:0002209 |
behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) |
| 0.1 |
1.8 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.1 |
0.3 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 |
0.6 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 |
0.4 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 |
0.4 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
0.6 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
0.9 |
GO:0034628 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
0.1 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.1 |
0.4 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.1 |
1.0 |
GO:0060174 |
limb bud formation(GO:0060174) |
| 0.1 |
1.6 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 |
1.0 |
GO:0021853 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.1 |
0.4 |
GO:0021683 |
cerebellar granular layer morphogenesis(GO:0021683) |
| 0.1 |
3.1 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.1 |
0.3 |
GO:0098911 |
regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
| 0.1 |
0.4 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.1 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.1 |
0.7 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 |
1.4 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
1.1 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.1 |
0.5 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
0.3 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.1 |
0.4 |
GO:0098976 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 |
1.4 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.1 |
0.5 |
GO:0051176 |
positive regulation of sulfur metabolic process(GO:0051176) |
| 0.1 |
1.8 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 |
0.1 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 |
1.1 |
GO:0072733 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.1 |
0.4 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.1 |
0.3 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
2.3 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 |
0.9 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 0.1 |
0.5 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 |
0.1 |
GO:1904252 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 |
2.9 |
GO:1901687 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 |
0.1 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 |
1.1 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.1 |
1.1 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.1 |
1.7 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.8 |
GO:1901355 |
cellular response to rapamycin(GO:0072752) response to rapamycin(GO:1901355) |
| 0.1 |
0.5 |
GO:1903333 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
| 0.1 |
0.3 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.1 |
0.5 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.1 |
0.1 |
GO:0048260 |
positive regulation of receptor-mediated endocytosis(GO:0048260) |
| 0.1 |
0.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
0.3 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
4.9 |
GO:0046676 |
negative regulation of insulin secretion(GO:0046676) |
| 0.1 |
1.1 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.1 |
0.6 |
GO:0070669 |
response to interleukin-2(GO:0070669) cellular response to interleukin-2(GO:0071352) |
| 0.1 |
3.7 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.1 |
0.8 |
GO:1990592 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.6 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 |
2.4 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.3 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.1 |
0.5 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.1 |
0.5 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 |
0.1 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.1 |
1.2 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.1 |
0.4 |
GO:2000854 |
positive regulation of corticosterone secretion(GO:2000854) |
| 0.1 |
1.2 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 |
0.6 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
1.1 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
1.7 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.1 |
0.5 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 |
0.6 |
GO:0021564 |
vagus nerve development(GO:0021564) |
| 0.1 |
0.4 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.1 |
GO:0003250 |
cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) cell proliferation involved in heart valve development(GO:2000793) |
| 0.1 |
1.3 |
GO:0046325 |
negative regulation of glucose import(GO:0046325) |
| 0.1 |
0.6 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.4 |
GO:0042214 |
terpene metabolic process(GO:0042214) |
| 0.1 |
0.1 |
GO:0034086 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.1 |
0.4 |
GO:0003095 |
pressure natriuresis(GO:0003095) |
| 0.1 |
1.2 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.1 |
0.8 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 |
0.2 |
GO:0006711 |
estrogen catabolic process(GO:0006711) |
| 0.1 |
0.4 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
0.4 |
GO:0006433 |
prolyl-tRNA aminoacylation(GO:0006433) |
| 0.1 |
0.5 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 0.1 |
0.9 |
GO:0046073 |
dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.1 |
0.1 |
GO:0045964 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.1 |
0.8 |
GO:0090266 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 |
0.5 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
1.5 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.3 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 |
0.1 |
GO:0045416 |
positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
| 0.1 |
0.5 |
GO:0051126 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.1 |
0.1 |
GO:0051462 |
cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 0.1 |
1.6 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.1 |
1.8 |
GO:0003323 |
type B pancreatic cell development(GO:0003323) |
| 0.1 |
0.5 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.1 |
0.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.3 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 |
1.4 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 |
0.2 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
1.4 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
5.7 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.8 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) |
| 0.1 |
0.3 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.1 |
0.1 |
GO:0002664 |
regulation of T cell tolerance induction(GO:0002664) |
| 0.1 |
0.3 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.1 |
GO:0006880 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 |
0.6 |
GO:0030949 |
positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 |
0.1 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) cellular response to muramyl dipeptide(GO:0071225) |
| 0.1 |
0.2 |
GO:0090045 |
positive regulation of deacetylase activity(GO:0090045) |
| 0.1 |
0.9 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.3 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.1 |
0.8 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.1 |
1.3 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.4 |
GO:1902572 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.1 |
0.8 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 |
0.2 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.1 |
0.2 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.1 |
0.2 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.1 |
0.1 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.1 |
2.0 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.1 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.1 |
0.4 |
GO:0015874 |
norepinephrine transport(GO:0015874) |
| 0.1 |
9.9 |
GO:1900181 |
negative regulation of protein localization to nucleus(GO:1900181) |
| 0.1 |
0.1 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.1 |
0.3 |
GO:0035349 |
coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.1 |
1.0 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
0.2 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.1 |
0.3 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 |
0.5 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.1 |
0.1 |
GO:0061356 |
Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
| 0.1 |
0.3 |
GO:0006754 |
ATP biosynthetic process(GO:0006754) |
| 0.1 |
1.1 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 |
0.6 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.1 |
0.7 |
GO:0042303 |
molting cycle(GO:0042303) hair cycle(GO:0042633) |
| 0.1 |
0.3 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
1.8 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.1 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 0.1 |
0.3 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.1 |
2.6 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 |
1.3 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
1.2 |
GO:1903432 |
regulation of TORC1 signaling(GO:1903432) |
| 0.1 |
1.0 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 |
0.1 |
GO:0002761 |
regulation of myeloid leukocyte differentiation(GO:0002761) |
| 0.1 |
0.3 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.1 |
0.5 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 |
0.8 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.2 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.1 |
1.3 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.8 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.4 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
0.2 |
GO:0042495 |
detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 0.1 |
10.7 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.1 |
0.3 |
GO:2000291 |
regulation of myoblast proliferation(GO:2000291) |
| 0.1 |
1.3 |
GO:0003016 |
respiratory system process(GO:0003016) |
| 0.1 |
0.4 |
GO:0051279 |
regulation of release of sequestered calcium ion into cytosol(GO:0051279) regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
0.5 |
GO:0015783 |
GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 |
0.3 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
0.1 |
GO:2000794 |
regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
| 0.1 |
0.2 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.1 |
0.5 |
GO:0039526 |
suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
| 0.1 |
0.3 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.1 |
2.5 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.6 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
1.2 |
GO:0097296 |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.1 |
0.3 |
GO:0040040 |
thermosensory behavior(GO:0040040) |
| 0.1 |
0.2 |
GO:0046834 |
lipid phosphorylation(GO:0046834) |
| 0.1 |
1.5 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.1 |
0.4 |
GO:0016334 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.1 |
0.6 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.1 |
0.5 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.1 |
0.2 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.1 |
1.3 |
GO:0042953 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
0.5 |
GO:0000271 |
polysaccharide biosynthetic process(GO:0000271) |
| 0.1 |
0.6 |
GO:0000291 |
nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 |
0.4 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
0.3 |
GO:0050688 |
regulation of defense response to virus(GO:0050688) |
| 0.1 |
0.4 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.1 |
0.8 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 |
0.9 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) |
| 0.1 |
1.0 |
GO:0014072 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
4.2 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
0.3 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.1 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.1 |
2.0 |
GO:0046006 |
regulation of activated T cell proliferation(GO:0046006) |
| 0.1 |
0.9 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.1 |
GO:1903401 |
L-lysine transmembrane transport(GO:1903401) |
| 0.1 |
0.4 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.3 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.1 |
0.1 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 0.1 |
1.2 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.1 |
0.2 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.1 |
0.9 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.3 |
GO:0050918 |
positive chemotaxis(GO:0050918) |
| 0.1 |
2.1 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.1 |
0.2 |
GO:2000553 |
positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.1 |
0.4 |
GO:0017185 |
peptidyl-lysine hydroxylation(GO:0017185) |
| 0.1 |
4.9 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.1 |
0.3 |
GO:0043536 |
positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.1 |
1.5 |
GO:0046348 |
amino sugar catabolic process(GO:0046348) |
| 0.1 |
0.7 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.1 |
0.2 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 |
0.2 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.1 |
1.2 |
GO:1901017 |
negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
| 0.1 |
0.3 |
GO:2001200 |
positive regulation of dendritic cell differentiation(GO:2001200) |
| 0.1 |
0.8 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
0.3 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.1 |
4.4 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
0.7 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.1 |
1.3 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 |
0.8 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.1 |
0.3 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.1 |
1.5 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 0.1 |
0.6 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.1 |
6.3 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.1 |
1.1 |
GO:0034397 |
telomere localization(GO:0034397) |
| 0.1 |
0.2 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.1 |
0.1 |
GO:0048841 |
regulation of axon extension involved in axon guidance(GO:0048841) |
| 0.1 |
0.1 |
GO:0033078 |
extrathymic T cell differentiation(GO:0033078) regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.1 |
0.7 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.5 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.7 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.1 |
0.3 |
GO:0040023 |
establishment of nucleus localization(GO:0040023) |
| 0.1 |
0.3 |
GO:0014065 |
phosphatidylinositol 3-kinase signaling(GO:0014065) |
| 0.1 |
0.9 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.1 |
0.8 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.1 |
0.2 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
0.1 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.1 |
0.1 |
GO:0009128 |
purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.1 |
0.1 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
5.1 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
14.5 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.1 |
0.1 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.1 |
2.9 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.1 |
0.3 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.1 |
0.2 |
GO:0044727 |
DNA demethylation of male pronucleus(GO:0044727) |
| 0.1 |
0.2 |
GO:0080184 |
response to phenylpropanoid(GO:0080184) |
| 0.1 |
0.1 |
GO:0032239 |
regulation of nucleobase-containing compound transport(GO:0032239) |
| 0.1 |
1.5 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
0.3 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.1 |
2.7 |
GO:0000272 |
polysaccharide catabolic process(GO:0000272) |
| 0.1 |
0.1 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 |
0.2 |
GO:0014010 |
regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) Schwann cell proliferation(GO:0014010) |
| 0.1 |
0.4 |
GO:0017187 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 |
0.8 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
0.1 |
GO:0002396 |
MHC protein complex assembly(GO:0002396) MHC class II protein complex assembly(GO:0002399) peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.1 |
0.2 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
0.6 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.6 |
GO:0034332 |
adherens junction organization(GO:0034332) |
| 0.1 |
0.2 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.1 |
0.6 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.5 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.1 |
0.6 |
GO:0060750 |
epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
| 0.1 |
0.7 |
GO:1900115 |
extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.1 |
0.2 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.1 |
0.3 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.1 |
0.5 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.1 |
0.2 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.1 |
0.1 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.2 |
GO:2001267 |
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
| 0.1 |
0.2 |
GO:1902308 |
regulation of peptidyl-serine dephosphorylation(GO:1902308) |
| 0.1 |
0.1 |
GO:0072021 |
ascending thin limb development(GO:0072021) metanephric ascending thin limb development(GO:0072218) |
| 0.1 |
0.8 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.2 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.1 |
0.5 |
GO:0019563 |
glycerol catabolic process(GO:0019563) |
| 0.1 |
0.2 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.1 |
1.0 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
0.7 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.1 |
0.3 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.2 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
1.0 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
0.1 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.1 |
0.1 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.1 |
0.3 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
0.4 |
GO:1903003 |
positive regulation of protein deubiquitination(GO:1903003) |
| 0.1 |
0.2 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.1 |
0.7 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 0.1 |
0.1 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.1 |
0.3 |
GO:0046092 |
deoxycytidine metabolic process(GO:0046092) |
| 0.1 |
0.6 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
0.6 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.8 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 |
0.1 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.1 |
0.5 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.1 |
0.1 |
GO:0070723 |
response to cholesterol(GO:0070723) |
| 0.1 |
1.8 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.1 |
0.4 |
GO:0072695 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 |
2.2 |
GO:0035036 |
sperm-egg recognition(GO:0035036) |
| 0.1 |
0.2 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 |
0.3 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.1 |
1.2 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.1 |
0.7 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.1 |
0.1 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 0.1 |
0.9 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 |
1.1 |
GO:1903078 |
positive regulation of protein localization to plasma membrane(GO:1903078) |
| 0.1 |
0.4 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.1 |
0.4 |
GO:0048705 |
skeletal system morphogenesis(GO:0048705) |
| 0.1 |
2.7 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.5 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.1 |
GO:0002327 |
immature B cell differentiation(GO:0002327) |
| 0.1 |
0.7 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 |
0.1 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.1 |
0.2 |
GO:0032972 |
regulation of muscle filament sliding speed(GO:0032972) |
| 0.1 |
0.4 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
0.1 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.1 |
0.1 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.1 |
0.2 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.1 |
0.5 |
GO:0072033 |
renal vesicle formation(GO:0072033) |
| 0.1 |
0.7 |
GO:0007501 |
mesodermal cell fate specification(GO:0007501) |
| 0.1 |
5.2 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
5.7 |
GO:0070268 |
cornification(GO:0070268) |
| 0.1 |
0.1 |
GO:0021650 |
vestibulocochlear nerve formation(GO:0021650) |
| 0.1 |
0.1 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.1 |
0.3 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.2 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.1 |
0.1 |
GO:0010713 |
negative regulation of collagen metabolic process(GO:0010713) negative regulation of multicellular organismal metabolic process(GO:0044252) |
| 0.1 |
1.6 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
| 0.1 |
0.3 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 |
0.7 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.1 |
0.5 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
0.5 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.1 |
0.2 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 |
0.2 |
GO:0035900 |
response to isolation stress(GO:0035900) |
| 0.1 |
0.3 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.1 |
0.2 |
GO:0016062 |
adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.1 |
0.4 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.1 |
0.2 |
GO:0070898 |
RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.1 |
0.6 |
GO:0034656 |
nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.1 |
0.1 |
GO:0002923 |
regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002923) |
| 0.1 |
0.1 |
GO:0048486 |
parasympathetic nervous system development(GO:0048486) |
| 0.1 |
1.0 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.1 |
1.5 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.1 |
0.7 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.2 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.1 |
0.1 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.1 |
0.1 |
GO:0010801 |
negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 |
0.2 |
GO:0001763 |
morphogenesis of a branching structure(GO:0001763) |
| 0.1 |
0.2 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.1 |
0.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.4 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.1 |
0.2 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.2 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.1 |
0.8 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.1 |
0.1 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.1 |
1.9 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.1 |
2.0 |
GO:0007044 |
cell-substrate junction assembly(GO:0007044) |
| 0.1 |
0.1 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 |
0.0 |
GO:0071287 |
cellular response to manganese ion(GO:0071287) |
| 0.0 |
0.1 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) |
| 0.0 |
0.4 |
GO:0071918 |
urea transmembrane transport(GO:0071918) |
| 0.0 |
0.1 |
GO:0048512 |
rhythmic behavior(GO:0007622) circadian behavior(GO:0048512) |
| 0.0 |
0.2 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.0 |
0.0 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.0 |
0.8 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.0 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.0 |
0.1 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.0 |
0.2 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.0 |
0.6 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.0 |
0.5 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.3 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.0 |
0.2 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
0.1 |
GO:0002323 |
natural killer cell activation involved in immune response(GO:0002323) |
| 0.0 |
0.2 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.0 |
0.8 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 |
0.1 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
0.3 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.0 |
0.6 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.3 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.0 |
0.0 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.0 |
1.0 |
GO:0015800 |
acidic amino acid transport(GO:0015800) |
| 0.0 |
0.1 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
| 0.0 |
0.1 |
GO:2000303 |
regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.0 |
0.0 |
GO:2000169 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.0 |
0.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.0 |
GO:0035995 |
detection of muscle stretch(GO:0035995) |
| 0.0 |
0.1 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.0 |
0.6 |
GO:0001707 |
mesoderm formation(GO:0001707) |
| 0.0 |
0.5 |
GO:0021984 |
adenohypophysis development(GO:0021984) |
| 0.0 |
0.5 |
GO:0042220 |
response to cocaine(GO:0042220) |
| 0.0 |
0.1 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.0 |
0.1 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.1 |
GO:2000659 |
regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 |
0.5 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
1.4 |
GO:0009584 |
detection of visible light(GO:0009584) |
| 0.0 |
0.1 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.0 |
0.2 |
GO:0097210 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.0 |
0.3 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 |
0.1 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.0 |
0.0 |
GO:0071317 |
cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.0 |
0.1 |
GO:0043634 |
polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.0 |
0.1 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.0 |
0.2 |
GO:0045766 |
positive regulation of angiogenesis(GO:0045766) |
| 0.0 |
0.1 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.0 |
1.1 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 |
0.3 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.0 |
0.6 |
GO:0051645 |
Golgi localization(GO:0051645) |
| 0.0 |
0.2 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.0 |
0.4 |
GO:0019720 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.0 |
0.1 |
GO:0002726 |
positive regulation of T cell cytokine production(GO:0002726) |
| 0.0 |
0.1 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.0 |
0.6 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
1.0 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.9 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.0 |
0.5 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.0 |
0.3 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.1 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.2 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.3 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.1 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.0 |
0.0 |
GO:0051125 |
regulation of actin nucleation(GO:0051125) |
| 0.0 |
0.4 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.2 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 |
0.1 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.0 |
0.2 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.0 |
0.4 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.0 |
0.3 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 |
0.0 |
GO:1903413 |
cellular response to bile acid(GO:1903413) |
| 0.0 |
5.8 |
GO:0010951 |
negative regulation of endopeptidase activity(GO:0010951) |
| 0.0 |
0.1 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 |
0.1 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.0 |
5.3 |
GO:0000377 |
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.0 |
0.0 |
GO:1904884 |
telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.0 |
0.4 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.4 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.0 |
0.1 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.0 |
0.2 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 |
0.0 |
GO:0060579 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.0 |
0.1 |
GO:0010755 |
regulation of plasminogen activation(GO:0010755) |
| 0.0 |
0.1 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.0 |
0.1 |
GO:1900044 |
regulation of protein K63-linked ubiquitination(GO:1900044) |
| 0.0 |
0.1 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.0 |
0.1 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.0 |
0.1 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 |
0.1 |
GO:0070173 |
regulation of enamel mineralization(GO:0070173) |
| 0.0 |
0.2 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.0 |
0.2 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.4 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.0 |
0.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
1.3 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.0 |
0.4 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.1 |
GO:0030730 |
sequestering of triglyceride(GO:0030730) |
| 0.0 |
0.0 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.0 |
0.5 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.0 |
0.1 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.0 |
0.0 |
GO:0021855 |
hypothalamus cell migration(GO:0021855) |
| 0.0 |
0.0 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.0 |
0.0 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.0 |
0.1 |
GO:0060283 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.0 |
0.0 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.0 |
0.1 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.0 |
0.0 |
GO:0009582 |
detection of abiotic stimulus(GO:0009582) |
| 0.0 |
0.2 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
| 0.0 |
0.1 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.0 |
0.1 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.0 |
0.1 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.0 |
0.1 |
GO:0043438 |
acetoacetic acid metabolic process(GO:0043438) |
| 0.0 |
0.0 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.0 |
0.4 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.0 |
0.0 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
1.1 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
0.0 |
GO:0032438 |
melanosome organization(GO:0032438) |
| 0.0 |
0.2 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.0 |
0.1 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.0 |
0.1 |
GO:0050976 |
detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.0 |
0.1 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.0 |
GO:0071288 |
cellular response to mercury ion(GO:0071288) |
| 0.0 |
0.9 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
0.5 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.0 |
0.0 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 |
0.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.1 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.0 |
0.1 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.0 |
0.3 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
0.0 |
GO:1904238 |
mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) pericyte cell differentiation(GO:1904238) |
| 0.0 |
0.0 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.0 |
0.4 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
0.0 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 0.0 |
0.0 |
GO:1904117 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.0 |
0.1 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.0 |
0.3 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 |
0.1 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 |
0.1 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.0 |
0.0 |
GO:0042533 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.0 |
0.2 |
GO:0042044 |
fluid transport(GO:0042044) |
| 0.0 |
0.0 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 |
0.1 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.0 |
0.1 |
GO:0072584 |
caveolin-mediated endocytosis(GO:0072584) |
| 0.0 |
0.1 |
GO:0070233 |
negative regulation of T cell apoptotic process(GO:0070233) |
| 0.0 |
0.1 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.0 |
0.0 |
GO:0002577 |
regulation of antigen processing and presentation(GO:0002577) |
| 0.0 |
0.1 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.0 |
0.0 |
GO:2000765 |
regulation of cytoplasmic translation(GO:2000765) |
| 0.0 |
0.0 |
GO:1904100 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.0 |
0.2 |
GO:0015918 |
sterol transport(GO:0015918) |
| 0.0 |
0.1 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.0 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.0 |
0.1 |
GO:0010044 |
response to aluminum ion(GO:0010044) |
